標(biāo)題: Titlebook: Cardiac Pacing for the Clinician; Fred M. Kusumoto,Nora F. Goldschlager Book 2008Latest edition Springer-Verlag US 2008 Defibrillator.Impl [打印本頁(yè)] 作者: 馬用 時(shí)間: 2025-3-21 17:38
書目名稱Cardiac Pacing for the Clinician影響因子(影響力)
書目名稱Cardiac Pacing for the Clinician影響因子(影響力)學(xué)科排名
書目名稱Cardiac Pacing for the Clinician網(wǎng)絡(luò)公開度
書目名稱Cardiac Pacing for the Clinician網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cardiac Pacing for the Clinician被引頻次
書目名稱Cardiac Pacing for the Clinician被引頻次學(xué)科排名
書目名稱Cardiac Pacing for the Clinician年度引用
書目名稱Cardiac Pacing for the Clinician年度引用學(xué)科排名
書目名稱Cardiac Pacing for the Clinician讀者反饋
書目名稱Cardiac Pacing for the Clinician讀者反饋學(xué)科排名
作者: 多節(jié) 時(shí)間: 2025-3-21 21:48 作者: 神經(jīng) 時(shí)間: 2025-3-22 02:20 作者: 無(wú)聊點(diǎn)好 時(shí)間: 2025-3-22 05:20
pplementary material: .Since the publication of the first edition of Cardiac Pacing for the Clinician, the use of implantable cardiac devices has expanded rapidly. Certain classes of devices such as implantable loop recorders and cardiac resynchronization pacing systems were not commonly used when t作者: 圍巾 時(shí)間: 2025-3-22 09:18
https://doi.org/10.1007/978-3-322-86144-3al risk of significant morbidity and even mortality. The management of device complications has become a subspecialty of cardiology and cardiovascular surgery (1–5). It requires special training to acquire the skills for successful results.作者: 脫水 時(shí)間: 2025-3-22 14:36
https://doi.org/10.1007/978-3-322-86144-3svenous pacing and transesophageal pacing was demonstrated. Temporary pacing has become the standard method for providing immediate treatment of severe bradycardias and certain tachycardias for the past 20 years.作者: 脫水 時(shí)間: 2025-3-22 19:20 作者: Obscure 時(shí)間: 2025-3-23 00:20
https://doi.org/10.1007/978-3-322-86214-3is group of patients, the optimal pacing mode, pacing system and site of ventricular stimulation for sinus node dysfunction remains controversial. The available data for the diagnosis and treatment of sinus node dysfunction are reviewed in this chapter.作者: INCH 時(shí)間: 2025-3-23 04:10 作者: 斷言 時(shí)間: 2025-3-23 08:28
https://doi.org/10.1007/978-3-322-86415-4antable cardioverter-defibrillator (ICD). Complications related to the implanted device can also lead to a need for management within the critical care setting. Finally, a permanent cardiac device can interact, and at times interfere, with therapies such as intravenous monitoring line placement, and external cardioversion and defibrillation.作者: 煉油廠 時(shí)間: 2025-3-23 11:50 作者: addict 時(shí)間: 2025-3-23 15:10
Techniques for Temporary Pacingsvenous pacing and transesophageal pacing was demonstrated. Temporary pacing has become the standard method for providing immediate treatment of severe bradycardias and certain tachycardias for the past 20 years.作者: 使?jié)M足 時(shí)間: 2025-3-23 19:09 作者: 笨拙的我 時(shí)間: 2025-3-23 22:16
Sinus Node Dysfunctionis group of patients, the optimal pacing mode, pacing system and site of ventricular stimulation for sinus node dysfunction remains controversial. The available data for the diagnosis and treatment of sinus node dysfunction are reviewed in this chapter.作者: 放大 時(shí)間: 2025-3-24 02:31 作者: chapel 時(shí)間: 2025-3-24 06:46 作者: 小步走路 時(shí)間: 2025-3-24 11:22 作者: 溫室 時(shí)間: 2025-3-24 16:19
https://doi.org/10.1007/978-3-322-85575-6uccessful LV lead implantation have been achieved through collective sharing of implant experiences (5). New sheath delivery systems, catheters, and guide wires continue to improve LV lead implantation success. It is hoped that this chapter will serve as a useful springboard to improving outcomes with LV lead implantation.作者: 真繁榮 時(shí)間: 2025-3-24 19:05 作者: isotope 時(shí)間: 2025-3-24 23:53 作者: 最小 時(shí)間: 2025-3-25 04:06 作者: 不愿 時(shí)間: 2025-3-25 08:46
Modes of Pacemaker Functionentricle. The third position represents the function that the pacemaker performs: triggered (T), inhibited (I), triggered and inhibited (dual or D), or none (O). . refers to pacing in the chamber paced after the sensing of intrinsic activity in the chamber sensed. The sensing and pacing may occur in different chambers.作者: 地牢 時(shí)間: 2025-3-25 13:41
Acquired Atrioventricular Blocky (ACC/AHA/NASPE) guidelines for pacemaker implantation (1). The indications for permanent pacing in second- or third- degree AV block unlikely to regress are often straightforward in . patients but they are more difficult in . patients.作者: syring 時(shí)間: 2025-3-25 18:16 作者: 平常 時(shí)間: 2025-3-25 22:19
https://doi.org/10.1007/978-3-322-86330-0pes, characterized by a sudden failure of the autonomic nervous system (ANS) to maintain blood pressure, and occasionally heart rate, at a level sufficient to maintain cerebral perfusion and consciousness (2–4). Syncope accounts for 3.5% of all emergency room visits and 1–6% of all hospital admissions annually in the USA (5).作者: 精致 時(shí)間: 2025-3-26 03:26
https://doi.org/10.1007/978-3-322-86415-4equirements of children. These requirements include the need for small size, but they also include flexibility in programmability, to take into account potentially higher levels of activity, higher natural heart rates, and the wide spectrum of problems encountered with congenital heart disease.作者: anniversary 時(shí)間: 2025-3-26 08:01
Cardiac Resynchronization Therapy for Congestive Heart Failurerch in this area. Now we have several published large scale randomized controlled trials that prove CRT not only improves symptoms, but also decreases mortality. Based on these trials, CRT has become the standard of care for selected patients with moderate to severe heart failure.作者: GLOSS 時(shí)間: 2025-3-26 08:32
Pacemakers and Syncopepes, characterized by a sudden failure of the autonomic nervous system (ANS) to maintain blood pressure, and occasionally heart rate, at a level sufficient to maintain cerebral perfusion and consciousness (2–4). Syncope accounts for 3.5% of all emergency room visits and 1–6% of all hospital admissions annually in the USA (5).作者: Visual-Field 時(shí)間: 2025-3-26 16:42
Cardiac Device Therapy in Childrenequirements of children. These requirements include the need for small size, but they also include flexibility in programmability, to take into account potentially higher levels of activity, higher natural heart rates, and the wide spectrum of problems encountered with congenital heart disease.作者: 馬籠頭 時(shí)間: 2025-3-26 19:51
Book 2008Latest editionclasses of devices such as implantable loop recorders and cardiac resynchronization pacing systems were not commonly used when the first edition was published, and recent studies have shown that implantable cardioverter defibrillators are beneficial in large, previously unrecognized patient populati作者: 橫截,橫斷 時(shí)間: 2025-3-26 21:10
Pacing Leadsction is to interface the power source and sophisticated electronics of the pulse generator with the heart. The pacemaker lead plays a critical role in delivering both the output pulse from the pulse generator to the myocardium and the intracardiac electrogram from the myocardium to the sensing circuit of the pulse generator.作者: 發(fā)展 時(shí)間: 2025-3-27 03:36 作者: Flawless 時(shí)間: 2025-3-27 06:40 作者: 在駕駛 時(shí)間: 2025-3-27 13:13
https://doi.org/10.1007/978-3-322-95933-1ction is to interface the power source and sophisticated electronics of the pulse generator with the heart. The pacemaker lead plays a critical role in delivering both the output pulse from the pulse generator to the myocardium and the intracardiac electrogram from the myocardium to the sensing circuit of the pulse generator.作者: Mast-Cell 時(shí)間: 2025-3-27 15:48
Fred M. Kusumoto,Nora F. GoldschlagerDiscusses the "nuts and bolts" of cardiac devices.Primer for the clinical cardiologist that is interested in device implantation.Includes supplementary material: 作者: 改正 時(shí)間: 2025-3-27 20:09
http://image.papertrans.cn/c/image/221805.jpg作者: 帳單 時(shí)間: 2025-3-28 01:53
https://doi.org/10.1007/978-3-322-95933-1ction is to interface the power source and sophisticated electronics of the pulse generator with the heart. The pacemaker lead plays a critical role in delivering both the output pulse from the pulse generator to the myocardium and the intracardiac electrogram from the myocardium to the sensing circ作者: Sciatica 時(shí)間: 2025-3-28 05:23 作者: intertwine 時(shí)間: 2025-3-28 09:42
https://doi.org/10.1007/978-3-322-85575-6 has, however, been an interesting parallel in the development of their methods of implantation (1). This has largely been driven by the dramatic advances in technology. In 1958, Seymour Furman and J.B. Schwedel passed the first transvenous endocardial electrode for prolonged cardiac pacing (2). Alm作者: 恃強(qiáng)凌弱 時(shí)間: 2025-3-28 12:43 作者: Lipohypertrophy 時(shí)間: 2025-3-28 16:37 作者: 本土 時(shí)間: 2025-3-28 19:16
https://doi.org/10.1007/978-3-322-86144-3e early 1950s Zoll successfully resuscitated an asystolic patient using temporary transcutaneous pacing. Later in that decade, the feasibility of transvenous pacing and transesophageal pacing was demonstrated. Temporary pacing has become the standard method for providing immediate treatment of sever作者: 驚呼 時(shí)間: 2025-3-29 01:37
https://doi.org/10.1007/978-3-322-86430-7vices consisted of a large generator placed in an abdominal pocket capable only of high-energy shocks. In the 25 years since the first implantation in humans (1), advances in technology have resulted in significantly smaller devices, with sophisticated detection algorithms and tiered therapies. Desp作者: 笨重 時(shí)間: 2025-3-29 04:01 作者: Introvert 時(shí)間: 2025-3-29 09:18
https://doi.org/10.1007/978-3-322-86214-3ardiac skeleton is the most common cause of chronic acquired AV block. Barring congenital AV block, Lyme disease is the most common cause of reversible third-degree AV block in young individuals and it is usually AV nodal. Before implantation of a permanent pacemaker, reversible causes of AV block s作者: Bother 時(shí)間: 2025-3-29 11:24
Wolfgang Kr?tschmer,Manfred Thummll many end-stage patients, who despite optimal medical management, still have severe and refractory symptoms, along with an overall poor prognosis (1,2). Cardiac resynchronization therapy (CRT), which is also known as biventricular pacing has been shown to be an effective nonpharmacologic approach 作者: 高原 時(shí)間: 2025-3-29 19:35
https://doi.org/10.1007/978-3-322-85635-7 cardiac pacing (1–3). Clinical trials have demonstrated that atrial pacing prevents paroxysmal and persistent AF in the general pacemaker population and the greatest benefit is observed in patients with sinus node disease (1–4). Many dual chamber pacemakers now have specific algorithms designed to 作者: synovial-joint 時(shí)間: 2025-3-29 22:46
https://doi.org/10.1007/978-3-322-86330-0tural tone and followed by a rapid and usually complete recovery. Syncope may be both benign or the only warning before an episode causing sudden death (1). Recurrent episodes of syncope may result from a variety of disorders, all of which cause a temporary reduction in cerebral blood flow sufficien作者: CHAFE 時(shí)間: 2025-3-30 02:55 作者: Plaque 時(shí)間: 2025-3-30 04:18 作者: grounded 時(shí)間: 2025-3-30 08:53 作者: Pillory 時(shí)間: 2025-3-30 13:09 作者: 點(diǎn)燃 時(shí)間: 2025-3-30 18:08
The Pulse GeneratorA cardiac pulse generator is a device having a power source and electronic circuitry that produce output stimuli. Functionally, at its simplest, current sourced by the device’s battery travels through a connecting pathway to stimulate the heart and then flows back into the pacemaker to complete the circuit.作者: Binge-Drinking 時(shí)間: 2025-3-30 22:40
Pacing Leadsction is to interface the power source and sophisticated electronics of the pulse generator with the heart. The pacemaker lead plays a critical role in delivering both the output pulse from the pulse generator to the myocardium and the intracardiac electrogram from the myocardium to the sensing circ
